A research team have recently published their article, “Rationally designed pooled CRISPRi-seq uncovers an inhibitor of bacterial peptidyl-tRNA hydrolase” in Cell Reports. In this study, the team created a collection of bacterial mutants to help them understand how a new type of antimicrobial molecule, discovered with their artificial intelligence tools, stops bacteria from growing.
Q&A: Discovery opens up possibilities for new AI-developed antibiotic
